> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Source Plasma Donor Screening Guidance
- URL: https://www.fdaweb.com/source-plasma-donor-screening-guidance/
- Published: 2020-05-20T12:00:00.000Z
- Updated: 2026-09-14T16:15:26.000Z
- Author: David McFarland
- Tags: Biologics, #legacy-id-D5146823

FDA has issued a guidance, *Implementation of Acceptable Full-Length and Abbreviated Donor History Questionnaires and Accompanying Materials for Use in Screening Donors of Source Plasma*, to recognize the May 2020 version 2.1 standard full-length and abbreviated donor history questionnaires and accompanying materials prepared by the Plasma Protein Therapeutics Association (PPTA). The [document](https://www.fda.gov/media/124172/download?ref=fdaweb.com) also advises source plasma manufacturers on how to report the implementation of the acceptable PPTA source plasma donor history questionnaire (SPDHQ) and accompanying materials.

The guidance supersedes a 7/2016 document on the same subject. Contents of the new guidance are Introduction, Background, Recognition of SPDHQ Documents, Reporting Implementation of Acceptable SPDHQ Documents, For More Information, and References.